Neurobiology of Disease 166 ( 2022 ) 105651 Available online 3 February 2022 0969 - 9961 / © 2022 The Authors . Published by Elsevier Inc . This is an open access article under the CC BY - NC - ND license ( http : / / creativecommons . org / licenses / by - nc - nd / 4 . 0 / ) . Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases Maria Izco , Estefania Carlos , Lydia Alvarez - Erviti * Laboratory of Molecular Neurobiology , Center for Biomedical Research of La Rioja ( CIBIR ) , Piqueras 98 , 3 th floor , 26006 Logro ˜ no , Spain A R T I C L E I N F O Keywords : Alzheimer ’ s disease Parkinson ’ s disease Endolysosomal dysfunction Exosomes Pathology progression A B S T R A C T Although the factors contributing to the pathogenesis of neurodegenerative diseases remain elusive , endolyso - somal pathway is emerging as a key player in the pathogenesis of neurodegenerative diseases . The link between endolysosomal dysfunction and neurodegeneration is supported by genetic studies identifying disease mutations in genes controlling endolysosomal function . Growing evidence suggests that endolysosomal dysfunction affect the production , secretion and content of exosomes . Current data suggests that exosomes play a key role in Parkinson ’ s disease ( PD ) and Alzheimer ’ s disease ( AD ) progression , interfering with the transmission of path - ological proteins or neuroinflammatory factors related to neurodegenerative diseases . This review summarizes recent advances in the role of endolysosomal dysfunction in the spreading of pathological proteins mediated by exosomes in the two most common neurodegenerative diseases , AD and PD . 1 . Introduction Neurodegenerative diseases are one of the most frequent pathol - ogies , with Alzheimer ’ s disease ( AD ) and Parkinson ’ s disease ( PD ) being the most common neurodegenerative disorders worldwide . Neurode - generative diseases are characterized by the accumulation of specific proteins in the brain and a progressive loss of susceptible neuronal populations in specific brain regions , responsible for the development of cognitive and motor deficits ( DeTure and Dickson , 2019 ; Lees et al . , 2009 ) . Although the factors initiating or contributing to the pathogen - esis of neurodegenerative diseases remain elusive for the majority of patients , several possible pathogenic mechanisms have been implicated , including autophagy and endolysosomal dysfunction , impaired mito - chondrial function , oxidative stress , altered protein degradation system , accumulation of misfolded proteins and neuroinflammation ( Jellinger , 2010 ) . Endolysosomal pathway is emerging as a key player in the patho - genesis of neurodegenerative diseases . The endolysosomal system is a highly regulated and complex network of membrane organelles specialized in regulating intracellular trafficking , protein recycling and degradation required for maintaining the proper protein homeostasis and membrane organization in the cell . It is inextricably intersected with autophagy and phagocytosis since all these pathways converge at the lysosome for final degradation ( Lamb et al . , 2013 ) . Defective endoly - sosomal function has been related to neuronal dysfunction and is extensively documented in neurodegenerative diseases ( Giovedi et al . , 2020 ; Kett and Dauer , 2016 ; Van Acker et al . , 2019 ; Wang et al . , 2017 ) . Human genome - wide association studies have identified several muta - tions in genes involved in endolysosomal function as potential risk factors of AD ( Guimas Almeida et al . , 2018 ) and PD ( Erb and Moore , 2020 ) . Mutations in these genes lead to dysfunction in different steps of the endolysosomal network , autophagy , endocytic trafficking or lyso - somal degradation , resulting in accumulation of neurodegenerative disease - related pathogenic proteins , such as amyloid beta ( A β ) and tau in AD and alpha - synuclein in PD ( Arbo et al . , 2020 ; Vidyadhara et al . , 2019 ) . Increasing evidence links endolysosomal pathway with the genera - tion and secretion of exosomes into the brain extracellular space and , recently , research focus in endolysosomal dysfunction related to neurodegenerative diseases has extended to exosomes . Exosomes are Abbreviations : A β , amyloid beta ; AD , Alzheimer ’ s disease ; APP , Amyloid precursor protein ; CSF , cerebrospinal fluid ; DS , Down syndrome ; ESCRT , endosomal sorting complexes required for transport ; ILV , intraluminal vesicles ; iPSC , induced pluripotent stem cells ; LB , Lewy bodies ; LRKK2 , leucine - rich repeat kinase 2 ; MVBs , multivesicular bodies ; NFTs , Neurofibrillary tangles ; PD , Parkinson ’ s disease ; PSEN , presenilin ; SNCA , alpha - synuclein gene ; SNpc , substantia nigra pars compacta . * Corresponding author . E - mail address : laerviti @ riojasalud . es ( L . Alvarez - Erviti ) . Contents lists available at ScienceDirect Neurobiology of Disease journal homepage : www . elsevier . com / locate / ynbdi https : / / doi . org / 10 . 1016 / j . nbd . 2022 . 105651 Received 30 September 2021 ; Received in revised form 11 January 2022 ; Accepted 25 January 2022 Neurobiology of Disease 166 ( 2022 ) 105651 2 extracellular vesicles generated within and released from endosomal compartments , which have been suggested to play a central role in the spreading and progression of neurodegenerative diseases ( Howitt and Hill , 2016 ; Yuan et al . , 2021 ) . Exosomes are released into the extracel - lular space and internalized by recipient cells delivering the exosomal content in the target cells . Exosomal cargoes , including disease - related proteins , inflammatory and neurotoxic factors and miRNAs , have been demonstrated to contribute to neurodegenerative disease progression facilitating the spread of pathological proteins , activating immune cells to propagate the neuroinflammatory response or inducing changes in the genetic program of the target cells ( Izco et al . , 2021 ) . Under path - ological conditions , defects in neuronal endolysosomal system appear to affect the production , secretion and content of exosomes , affecting therefore the progression of neurodegenerative diseases . In this review , we focus on the role of endolysosomal dysfunction in the spreading of pathological proteins and inflammatory factors mediated by exosomes in the two most common neurodegenerative diseases , AD and PD . 2 . Exosome biogenesis and secretion within endocytic pathway Exosomes are nanosized extracellular vesicles ( 30 – 100 nm of diam - eter ) that originate from the endocytic pathway during the process of endosomal maturation ( Raposo and Stoorvogel , 2013 ) . The endocytic pathway is composed of early endosomes , late endosomes , recycling endosomes and lysosomes , which regulate protein recycling and degradation . Endosomes undergo a maturation process characterized by different biological and morphological changes , as formation of intra - luminal vesicles , increase in luminal acidification , movement in space along a microtubule toward the perinuclear region and the conversion of Rab proteins ( Huotari and Helenius , 2011 ) . The Rab family of small GTPases is a set of GTP - binding proteins that regulate intracellular molecular trafficking and sorting along the endocytic pathway by coordinating the biogenesis , transport and fusion of organelles bound to membrane and vesicles ( Homma et al . , 2021 ) . Endocytosis or protein uptake into cells is initiated by the formation of clathrin and caveolar - coated endocytic vesicles derived from the plasma membrane and other less characterized endocytic pathways ( Elkin et al . , 2016 ) . These vesicles containing endocytosed cargoes fuse with early endosomes , a process regulated mainly by Rab5 . Early endosomes act as an initial sorting station from where some molecules are recycled back to the plasma membrane ( Li and DiFiglia , 2012 ) , routed to the trans - Golgi network and endoplasmatic reticulum through retrograde transport mediated by retromer complex ( Seaman , 2012 ) , or targeted to late endosomes and finally to lysosomes for degradation ( Scott et al . , 2014 ) ( Fig . 1 ) . The maturation of early endosomes to late endosomes is initiated by the formation of intraluminal vesicles ( ILV ) through inward budding of the membrane , a process triggered by ubiquitin and regulated by endosomal sorting complexes required for transport ( ESCRT ) machin - ery , forming multivesicular bodies ( MVBs ) ( Piper and Katzmann , 2007 ) . Endosomal maturation process involves Rab replacement , movement to the perinuclear area and luminal acidification . Once endosomal matu - ration is completed , MVB or late endosomes fuse with lysosomes or with autophagosomes to form amphisomes that fuse with lysosomes , ulti - mately leading to protein degradation . This point is the intersection between endocytic and autophagic pathway . Alternatively , MVB can fuse with the membrane plasma to release the ILV into the extracellular space as exosomes ( Fig . 1 ) . The signals and molecular mechanisms that regulate the fate of the MVBs to plasma membrane or lysosomes are still not well understood . Moreover , the final destination of MVBs could change under specific physiological and pathological conditions ( Hessvik and Llorente , 2018 ) . ISGylation , an ubiquitin - like posttranslational modification , has been suggested as one of the signals that reduces exosome secretion by pro - moting lysosomal degradation of MVB proteins ( Villarroya - Beltri et al . , 2016 ) . In line with this , autophagy induction , either by physiological Fig . 1 . Endolysosomal - exosome system . Following endocytosis , the endocytosed components enter the early endosomes , from where selected cargo is either recycled back to the cell membrane , routed to the trans - Golgi network by retrograde transport mediated by retromer complex or targeted to late endosomes / MVB and lysosomes for degradation . MVBs are able to fuse with lysosomes or with autophagosomes to form amphisomes that fuse with lysosomes , ultimately leading to protein degradation . Alternatively , MVB can fuse with the membrane plasma to release ILV into the extracellular space as exosomes . M . Izco et al . Neurobiology of Disease 166 ( 2022 ) 105651 3 ( starvation ) or pharmacological ( rapamycin treatment ) stimulus , has also been demonstrated to inhibit exosome secretion promoting fusion of MVBs with autophagic vacuoles in K562 cells ( Fader et al . , 2008 ) . Cortactin , an actin binding protein , is involved in the trafficking and fusion of MVBs to the plasma membrane and knockdown or over - expression of cortactin has been shown to decrease or increase exosome release , respectively ( Sinha et al . , 2016 ) . The final fate of the MVBs to lysosomal degradation or secretion also depends on cellular homeosta - sis , in such a way that cellular stress , senescence or hypoxia increase exosome secretion ( Kanemoto et al . , 2016 ; King et al . , 2012 ; Lehmann et al . , 2008 ) . Finally , lysosomes play a key role in the regulation of the exosome release and it has been observed that lysosomal dysfunction by treatment with bafilomycin A or chloroquine increases exosome secre - tion ( Alvarez - Erviti et al . , 2011 ; Ortega et al . , 2019 ) . 3 . Interplay between endolysosomal dysfunction and exosomes in neurodegenerative diseases 3 . 1 . Alzheimer ’ s disease AD is the most prevalent neurodegenerative disease worldwide and the main cause of dementia . AD patients show a progressive decline in memory function and increasing cognitive impairments as disease pro - gresses . Pathologically , AD is characterized by the presence of extra - cellular senile plaques , comprised of A β peptide , neurofibrillary tangles ( NFTs ) , composed of hyperphosphorylated tau protein , and neuronal death ( Serrano - Pozo et al . , 2011 ) . Several in vivo studies have demon - strated that both A β and tau pathological forms propagate between anatomically and functionally connected brain regions through a prion - like mechanism ( Clavaguera et al . , 2009 ; Meyer - Luehmann et al . , 2006 ; Yin et al . , 2014 ) . Increasing evidence highlights the key role of exosomes Fig . 2 . Exosomal progression of AD pathology . a ) Cell - to - cell transmission of pathological forms of A β and tau mediated by exosomes . b ) Impaired endolysosomal pathway , one of the earliest pathological feature of AD , as well as several APP and APOE4 mutations and genetic AD risk factors involved in endosomal trafficking lead to increased secretion of AD - related proteins mediated by exosomes . c ) Exosomes released from glial cells containing neurotoxic factors , A β and tau seeds contribute to AD progression and neurodegeneration . M . Izco et al . Neurobiology of Disease 166 ( 2022 ) 105651 4 in the transmission of these pathological forms of A β and tau throughout the brain , affecting the progression of AD ( Song et al . , 2020 ; Xiao et al . , 2017 ) . Both A β and tau are secreted from cells in association with exosomes ( Fig . 2a ) . A β derives from the sequential cleavage of the amyloid pre - cursor protein ( APP ) by β - and γ - secretases , and MVB and exosomes have been suggested to be the site of APP β - cleavage and A β oligomerization ( Rajendran et al . , 2006 ; P ´ erez - Gonz ´ alez et al . , 2020 ) . Exosomal A β was reported the first time by Rajendran et al . ( 2006 ) , who observed that N2a cells expressing the Swedish mutant APP secrete exosomes con - taining A β . Subsequently , numerous studies have identified exosomes derived from brain of AD mouse models ( Perez - Gonzalez et al . , 2012 ) , as well as from brain ( Sardar Sinha et al . , 2018 ) , cerebrospinal fluid ( CSF ) ( Eitan et al . , 2016a ) and blood ( Fiandaca et al . , 2015 ) AD samples , containing monomeric and oligomeric forms of A β . More importantly , exosomes containing oligomeric A β isolated from AD brains are taken up by SH - SY5Y cells , causing cytotoxicity and transmission to further recipient cells ( Sardar Sinha et al . , 2018 ) . A recent study has demon - strated that intracranial injection of exosomes derived from 5xFAD transgenic AD mouse brains into WT mice resulted in the internalization of the exosomes by healthy neurons , leading to mitochondrial damage and neurotoxicity ( Elsherbini et al . , 2020 ) . Numerous studies have revealed the presence of phosphorylated tau in exosomes derived from brain tissue of mouse models of tauopathy ( Baker et al . , 2016 ; Polanco et al . , 2016 ) as well as from CSF ( Saman et al . , 2012 ; Wang et al . , 2017b ) and blood ( Fiandaca et al . , 2015 ; Winston et al . , 2016 ) samples from AD patients . Tau forms contained in those exosomes facilitate tau aggregation in cultured recipient cells and in vitro devices designed to assess tau seeding capacity ( Baker et al . , 2016 ; Polanco et al . , 2016 ; Wang et al . , 2017b ) . Moreover , hippocampal injection of exosomes isolated from tau transgenic rTg4510 mouse brains accelerated tau phosphorylation and triggered formation of endogenous tau oligomers in ALZ17 mice ( Baker et al . , 2016 ) . The same results were observed in WT mice injected with exosomes isolated from induced pluripotent stem cells ( iPSC ) derived from familial AD patients ( Aulston et al . , 2019 ) or transduced with mutant tau ( Reilly et al . , 2017 ; Winston et al . , 2019 ) . In the same line , injection in mice of enriched neuronal exosomes isolated from AD plasma samples also caused an increase in phosphorylated tau in the hippocampus compared to exo - somes derived from healthy patients ( Winston et al . , 2016 ) . Interest - ingly , not only neurons but also microglial cells have been reported to facilitate tau spreading between neurons by taking up and releasing exosomes containing pathological forms of tau ( Asai et al . , 2015 ) . In vivo evidence of the key role of exosomes in AD progression was provided by animal studies demonstrating that inhibition of exosome secretion using GW4869 , a inhibitor of neutral sphingomyelinase 2 , results in the reduction of amyloid plaque load in the brain of 5xFAD mouse model of AD ( Dinkins et al . , 2014 ) as well as tau propagation in a AAV - tau mouse model ( Asai et al . , 2015 ) . Therefore , affecting the for - mation and / or the secretion of exosomes can interfere with the trans - mission of pathological forms of AD - related proteins . Accumulating evidence shows that perturbations in the endolysosomal system can affect exosome biogenesis , secretion and content ( Eitan et al . , 2016b ; Miranda et al . , 2018 ; Ortega et al . , 2019 ) . Increasing in vitro and in vivo studies emphasize the crucial role of the endolysosomal system dysfunction in AD pathogenesis ( Lai et al . , 2021 ) . Abnormalities of the endolysosomal network are the earliest pathological features of AD including enlargement and increased numbers of endosomes as well as disturbances in endocytosis and flux through endolysosomal compartment ( Cataldo et al . , 2000 ) , which affect biogenesis and clearance of A β and tau leading to their accumu - lation . Evidence suggests that endolysosomal dysfunction lead to altered secretion of AD - related proteins mediated by exosomes . It has been re - ported that the disruption of the retromer complex activity induces an increase in the amount of A β in secreted exosomes ( Sullivan et al . , 2011 ) ; the same results have been observed recently using Drosophila larval neuromuscular junctions ( Walsh et al . , 2021 ) . Inhibition of lyso - somal function using chloroquine ( Yuyama et al . , 2008 ) or bafilomycin A , or CRISPR - Cas9 cathepsin D knockdown in cells expressing mutant presenilin 1 ( PSEN1 ) ( Eitan et al . , 2016a ) also resulted in increased amount of A β secreted in exosomes . Although increased exosomal secretion has been proposed to be a compensatory mechanism to remove pathological proteins from cells , further studies are required to inves - tigate whether these exosomes contribute to cell - to - cell propagation of AD pathology . Noteworthy , not only A β and tau , but also other signaling , neurotoxic and inflammatory factors and miRNAs related to AD are secreted in exosomes . Several studies have showed changes in the content of exosomes derived from cells treated with A β 42 proto - fibrils ( Nikitidou et al . , 2017 ) , AD mouse brains ( Hurwitz et al . , 2018 ) and plasma samples of AD patients ( Goetzl et al . , 2018 ) compared to control exosomes . However , whether these exosomal contents contribute to cell - to - cell spreading of AD pathology is unknown and research into exosomal cargo may provide further understanding of AD progression . Familial forms of AD , characterized by early - onset , represent only 1 % of all AD cases , however , several mutations and genetic risk factors of AD have been involved in endosomal trafficking ( Guimas Almeida et al . , 2018 ) ( Table 1 ) and , consequently , could be linked to exosome biology ( Fig . 2b ) . ApoE4 has been reported to dysregulate the endoly - sosomal pathway comprising brain exosome production ( Nuriel et al . , 2017 ; Peng et al . , 2019 ) . Exosome secretion is also enhanced in brain of patients with Down syndrome ( DS ) , who present an extra copy of the APP gene by triplication of chromosome 21 ( Gauthier et al . , 2017 ) . However , there are almost no studies that evaluate the impact of the genetic risk factors in the spreading of AD pathology by exosomes . Recently , it has been reported that expression of BIN1 , the second most significant locus associated to late onset AD and a regulator of endocy - tosis , regulates the exosomal tau release in HEK239T cells expressing mutant tau and exacerbates tau pathology in tau transgenic mice ( Crotti et al . , 2019 ) . A study published this year has demonstrated that neuron - derived exosomes isolated from blood of DS patients lead to abundant tau pathology in hippocampus of injected WT mice compared to age - matched control exosomes , contributing to disease spreading ( Ledreux et al . , 2021 ) . Finally , neuroinflammation plays a key role in AD pathogenesis and exosomes derived from glial cells have been involved in the spreading of AD - related proteins ( Fig . 2c ) . Asai et al . ( 2015 ) reported that exosomes containing tau derived from microglia are taken up by neurons and trigger abnormal tau aggregation , facilitating tau propagation . Micro - glia has been demonstrated to internalize A β protofibrils and release exosomes containing transmissible A β ( Gouwens et al . , 2018 ) . There - fore , endolysosomal dysfunction and altered exosome biology in glial cells could affect A β and tau transmission and AD progression . Only one study has investigated this interplay and demonstrated that deletion of Table 1 Endocytic genetic risk factors in AD . Gene Protein product Main function Citations APOE4 Apolipoprotein E4 Lipid transport ( Cataldo et al . , 2000 ) PICALM CALM Formation of endocytic vesicles ( Meyerholz et al . , 2005 ) CD2AP CD2AP Endosome maturation and sorting ( Gauthier et al . , 2007 ) SORL1 Sorla Retromer sorting ( Fjorback and Andersen , 2012 ) PLD3 Phospholipase D3 Endocytic trafficking ( Donaldson , 2009 ) CLU Clusterin Endocytic chaperone ( Harold et al . , 2009 ) RIN3 RIN3 Endocytic trafficking ( Shen et al . , 2020 ) BIN1 Bin1 Membrane dynamics and vesicle formation ( David et al . , 1996 ) M . Izco et al . Neurobiology of Disease 166 ( 2022 ) 105651 5 murine microglial Bin1 reduces tau release mediated by exosomes in vitro and decreases tau spreading in transgenic mice ( Crotti et al . , 2019 ) . 3 . 2 . Parkinson ’ s disease PD is the second most prevalent neurodegenerative disease world - wide and the most common movement disorder affecting ~ 1 % of the population over 65 years ( Kalia and Lang , 2015 ) . PD is pathologically characterized by the presence of intraneuronal Lewy bodies ( LB ) , ag - gregates containing phosphorylated alpha - synuclein , and the loss of dopaminergic neurons in the substantia nigra pars compacta ( SNpc ) , responsible for the motor deficits associated with PD ( Lees et al . , 2009 ) . PD patients also experience non - motor symptoms including disturbed sleep , hyposmia and gastrointestinal dysfunction that precede the onset of motor deficits by over a decade ( Schapira et al . , 2017 ) . Although the factors initiating or contributing to PD pathogenesis remain unclear , genetic , pathological and biochemical studies support a key role of alpha - synuclein in the pathogenesis of PD ; moreover , there is increasing evidence that cell - to - cell transmission of misfolded alpha - synuclein plays a central role in disease progression . The mechanisms involved in PD pathology progression remain still unclear , but exosomes have gained increasing attention and numerous studies suggest that exosomes contribute to PD progression not only facilitating the transference of pathological alpha - synuclein , but also activating immune cells and propagating neuroinflammatory response ( Izco et al . , 2021 ) . Exosomal alpha - synuclein was reported for the first time by Emma - nouilidou et al . ( 2010 ) , who identified monomeric and oligomeric alpha - synuclein in exosomes released by SH - SY5Y cells expressing alpha - synuclein . Subsequent studies have identified pathological forms of alpha - synuclein in exosomes released from neurons and glial cells ( Guo et al . , 2020 ; Xia et al . , 2019 ) , and in exosomes isolated from brain , blood and CSF of PD patients ( Han et al . , 2019 ; Ngolab et al . , 2017 ; Stuendl et al . , 2016 ) . Moreover , these studies provided in vivo evidence that injection of exosomes containing pathological alpha - synuclein are able to induce alpha - synuclein aggregation , dopaminergic degeneration and motor impairments in mice ( Guo et al . , 2020 ; Han et al . , 2019 ; Ngolab et al . , 2017 ; Stuendl et al . , 2016 ; Xia et al . , 2019 ) . Given the central role of exosomes in progression of PD pathology , modifications in production and / or secretion of exosomes can interfere with the transmission of pathological alpha - synuclein and neurotoxic inflammatory factors related to PD . We will focus on key findings related to endolysosomal dysfunctions leading to exosome biology impairments in the context of PD pathology . The interplay between endolysosomal system and exosome biology in the context of PD is supported by studies in familial PD cases . Although most cases of PD are sporadic , a subset of cases is inheritable and attributable to mutations in specific genes . Intriguingly , most of genes mutated in familial PD have links with the endolysosomal system ( Table 2 , Fig . 3a ) and , consequently , with exosome biology . However , few studies have evaluated the impact of PD - related gene mutations in the functionality of exosomes and further studies would be required . PARK9 , also known as ATP13A2 , was the first PD - associated gene involved in the biogenesis of exosomes and alpha - synuclein secretion . ATP13A2 encodes a lysosomal P5 - type ATPase and loss - of - function mutations in ATP13A2 / PARK9 result in Kufor - Rakeb syndrome ( Ram - irez et al . , 2006 ) , a form of autosomal PD characterized by juvenile - onset parkinsonism , pyramidal signs , and cognitive decline . ATP13A2 localizes to MVBs and regulates exosome biogenesis . Moreover , increased ATP13A2 levels reduce intracellular alpha - synuclein levels and increase exosomal alpha - synuclein secretion , regulating exosome biogenesis through functional interaction with the ESCRT machinery ( Kong et al . , 2014 ; Tsunemi et al . , 2014 ) . Another PD - linked gene involved in exosome biogenesis and alpha - synuclein secretion is GBA gene , which encodes the lysosomal enzyme glucocerebrosidase that cleaves the glycolipid glucocerebrosidase into glucose and ceramide . GBA mutations constitute the most important genetic risk factor for PD and are associated with decreased activity of glucocerebrosidase , altered lysosomal function and subsequent dysfunction of the endolysosomal system . Since ceramide is involved in exosome biogenesis ( Trajkovic et al . , 2008 ) , altered ceramide levels induced by deficiency in glucocerebrosidase could affect exosome for - mation and trafficking . A study publish recently using a GBA - deficient Drosophila model showed that GBA mutations alter the protein compo - sition of extracellular vesicles , influencing cell - to - cell spread of patho - logical protein aggregates ( Jewett et al . , 2021 ) . In the PD context , striatal expression of mutant GBA in mouse models of PD resulted in increased exosomal release of alpha - synuclein , enhancing alpha - synuclein spreading ( Papadopoulos et al . , 2018 ) . In agreement with these results , Cerri and colleagues used fibroblast cell lines derived from PD patients carrying GBA mutations to demonstrate that GBA mutations induce dysregulation of small extracellular vesicles trafficking promot - ing their release ( Cerri et al . , 2021 ) . More importantly , exosomes released from PD fibroblasts carrying severe GBA mutations increased the phosphorylation of alpha - synuclein in recipient SH - SY5Y cells expressing alpha - synuclein compared to exosomes released from control fibroblasts ( Cerri et al . , 2021 ) . Parkin , a multifunctional E3 ubiquitin ligase , has also been involved in exosome biogenesis . Mutations in the Parkin / PARK2 gene result in loss - of - function of the encoded parkin protein and cause autosomal - recessive juvenile PD . Although parkin plays an essential role in the mitochondrial dynamics and mitophagy ( Wang et al . , 2020 ) , it has also been demonstrated to regulate the endolysosomal pathway and retro - mer function affecting further ILV formation and exosome secretion ( Song et al . , 2016 ) . The authors observed that parkin mutations regulate Table 2 PD genes linked to endolysosomal system . Locus Gene Protein product Main function Citations PARK1 / 4 SNCA Alpha - synuclein Synaptic vesicle recycling ( Polymeropoulos et al . , 1997 ) ( Singleton et al . , 2003 ) PARK2 Parkin Parkin Mitophagy / Rab ubiquitination ( Dawson and Dawson , 2010 ) PARK6 PINK 1 PINK1 Mitophagy / Rab phosphorilation ( Valente et al . , 2004 ) PARK7 DJ1 DJ1 Mitophagy ( Lev et al . , 2006 ) PARK8 LRRK2 LRRK2 GTPase / Kinase ( Rui et al . , 2018 ) PARK9 ATP13A2 ATPase type 13A2 Endolysosomal ATPase ( Di Fonzo et al . , 2007 ) PARK16 RAB29 Ras - related protein Rab - 7 L1 Rab GTPase ( Satake et al . , 2009 ) PARK17 VPS35 VPS35 Retromer complex ( Williams et al . , 2017 ) PARK19 DNAJC6 Auxilin Endocytic co - chaperone ( Olgiati et al . , 2016 ) PARK20 SYNJ1 Synaptojanin - 1 Endocytic phosphatase ( Drouet and Lesage , 2014 ) PARK21 DNAJC13 RME - 8 Endocytic co - chaperone ( Vilari ˜ no - Güell et al . , 2014 ) PARK23 VPS13C VPS13C Retromer / Lipid transfer ( Schormair et al . , 2018 ) GBA Glucocerebrosidase 1 Lysosomal enzyme ( Sidransky and Lopez , 2012 ) GAK Cyclin - G Associated Kinase Endocytosis ( Chang et al . , 2017 ) SH3GL2 Endophilin A1 Endocytosis ( Chang et al . , 2017 ) M . Izco et al . Neurobiology of Disease 166 ( 2022 ) 105651 6 the formation of ILV by increasing inward vesiculation of endosomes leading to an enhanced release of exosomes in parkin - deficient fibro - blasts ( Song et al . , 2016 ) . However , the impact of parkin mutations on the functionality of these exosomes in the pathogenesis and progression of PD is currently unknown and further studies are required . A very recent study published this year has also linked the alpha - synuclein gene ( SNCA ) with endolysosomal dysfunction , exosome biogenesis and alpha - synuclein secretion . Five point mutations in SNCA identified so far are considered as the main responsible for the early onset of familial PD . Using human iPSC models of PD , Stykel and col - leagues have demonstrated that mutant alpha - synuclein sequesters the autophagy protein LC3B , which has been involved in exosome biogen - esis ( Xu et al . , 2018 ) , into oligomeric aggregates on MVBs surface inducing an increased secretion of alpha - synuclein via exosomes ( Stykel et al . , 2021 ) . Moreover , exosomes released from SNCA mutant neurons are able to seed alpha - synuclein in healthy wild type neurons in co - culture ( Stykel et al . , 2021 ) . LRRK2 acts at multiple points within the endosomal pathway regu - lating exosome biogenesis . R1441C LRRK2 pathological mutation in - duces the accumulation and formation of abnormally large MVBs ( Alegre - Abarrategui et al . , 2009 ) , possibly resulting in an increased exosome secretion and alpha - synuclein accumulation in the extracel - lular space . In addition , a recent in vitro study found significant gene expression changes in exosomes released from LRRK2 mutant iPSC - derived dopaminergic neurons compared to control exosomes ( Cande - lario et al . , 2020 ) . These alterations in the exosomal gene expression induced by pathological mutations associated to PD could affect numerous exosomal cargoes , as inflammatory mediators , neurotoxic factors and miRNAs , involved in pathogenesis and progression of PD . However , the majority of PD cases are sporadic . Noteworthy , the interplay between endolysosomal system , exosome biology and alpha - synuclein release is also supported by studies in sporadic PD cases . A hallmark of sporadic PD is the failure of the endolysosomal pathway as well as lysosomal dysfunction leading to accumulation of autophagic vesicles with incompletely cleared alpha - synuclein resulting in intra - cellular alpha - synuclein aggregates ( Alvarez - Erviti et al . , 2010 ; Chu et al . , 2009 ; Rocha et al . , 2020 ) . Studies in cell models demonstrated that impaired lysosomal function increases the release and transmission of alpha - synuclein mediated by exosomes ( Fig . 3b ) . Pharmacological inhibition of lysosomal activity with Bafilomycin A1 increased alpha - synuclein secretion in exosomes released from SH - SY5Y cells over - expressing alpha - synuclein ( Alvarez - Erviti et al . , 2011 ) . It has been suggested that increased alpha - synuclein exosomal secretion after lysosomal impairment could be a compensatory event for alpha - synuclein decreased clearance ; however this mechanism favors alpha - synuclein spreading . Interestingly , a decrease in GBA activity has been found in sporadic PD patients without mutations ( Gegg et al . , 2012 ; Murphy et al . , 2014 ; Rocha et al . , 2015 ) . Several studies have demon - strated that genetic or chemical depletion of glucocerebrosidase activity causes an excessive production and secretion of exosome and an increased secretion of oligomeric forms of alpha - synuclein mediated by exosomes , promoting the spreading of alpha - synuclein aggregates ( Bae et al . , 2014 ; Papadopoulos et al . , 2018 ; Thomas et al . , 2018 ) . Finally , neuroinflammation is increasingly recognized as a key player in the pathogenesis and progression of PD . Recently , the role of exosomes derived from glial cells in cell - to - cell transmission of patho - logical forms of alpha - synuclein and in the propagation of neuro - inflammatory response has gained increasing attention . In vitro and in vivo studies have shown that exosomes derived from microglia cells treated with alpha - synuclein preformed fibrils induce alpha - synuclein aggregation in recipient neurons in culture . The intrastriatal injection of those exosomes caused accumulation of phosphorylated alpha - synuclein in several brain regions , loss of dopaminergic cells and motor dysfunction in mice ( Guo et al . , 2020 ; Xia et al . , 2019 ) . Endoly - sosomal dysfunction and altered exosome biology in glial cells also affect alpha - synuclein spreading and PD progression . Recently , Jacquet et al . ( 2020 ) showed that astrocytes derived from iPSC cells carrying the LRRK2 G2019S mutation presented alterations in the morphology and distribution of MVBs as well as dysregulated gene expression of proteins involved in MVB trafficking , which affect the biogenesis of extracellular vesicle . Moreover , LRRK2 mutant astrocytes secrete exosomes with an enhanced accumulation of pathological alpha - synuclein and other key PD - related proteins , which provides a marginal trophic support to dopaminergic neurons compared to exosomes derived from wildtype astrocytes ( Jacquet et al . , 2020 ) . Additionally , whereas astrocytes have been found to prevent neuronal alpha - synuclein accumulation and alpha - synuclein transfer between neurons , ATP13A2 mutant astrocytes showed an impaired protective function , leading to an increased alpha - synuclein accumulation and transmission ( Tsunemi et al . , 2020 ) . 4 . Conclusions Recently , genetic , in vitro and in vivo research has emphasized the role of endolysosomal system dysfunction in the pathogenesis of Fig . 3 . Interplay between endolysosomal dysfunction and exosome biology in PD . a ) Genes mutated in familial PD converge on the endolysosomal system and , consequently , on exosome biology leading to increased exosomal release of alpha - synuclein and affecting PD pathology progression . b ) Impaired lysosomal function in sporadic PD brains increases alpha - synuclein secretion in exosomes favoring alpha - synuclein spreading . M . Izco et al . Neurobiology of Disease 166 ( 2022 ) 105651 7 neurodegenerative diseases , including AD and PD . Increasing evidence demonstrated that defective endolysosomal system affects the produc - tion , secretion and content of exosomes , therefore interfering with the transmission of pathological proteins and neuroinflammatory factors related to neurodegenerative diseases . Increasing our knowledge on the pathological mechanisms involved in the biogenesis , cargo and release of exosomes might provide novel strategies for therapeutic intervention in AD and PD as well as in other neurodegenerative diseases . Not only the inhibition of exosome secretion , but also modifying the content of exosomes by decreasing the exosomal cargo of pathological proteins , neuroinflammatory factors or altered miRNAs could open new thera - peutic strategies to halt the progression of neurodegenerative diseases . Furthermore , increasing the cargo of trophic factors in glial - derived exosomes could emerge as a new neurorestorative approach in the treatment of neurodegenerative diseases . Funding Lydia Alvarez Erviti is supported by a Miguel Servet II contract , Spain ( CPII20 / 00027 ) . Declaration of Competing Interest None . References Alegre - Abarrategui , J . , Christian , H . , Lufino , M . M . , Mutihac , R . , Venda , L . L . , Ansorge , O . , Wade - Martins , R . , 2009 . LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model . Hum . Mol . Genet . 18 , 4022 – 4034 . https : / / doi . org / 10 . 1093 / hmg / ddp346 . Alvarez - Erviti , L . , Rodriguez - Oroz , M . C . , Cooper , J . M . , Caballero , C . , Ferrer , I . , Obeso , J . A . , Schapira , A . H . , 2010 . Chaperone - mediated autophagy markers in Parkinson disease brains . Arch . Neurol . 67 , 1464 – 1472 . https : / / doi . org / 10 . 1001 / archneurol . 2010 . 198 . Alvarez - Erviti , L . , Seow , Y . , Schapira , A . H . , Gardiner , C . , Sargent , I . L . , Wood , M . J . , Cooper , J . M . , 2011 . Lysosomal dysfunction increases exosome - mediated alpha - synuclein release and transmission . Neurobiol . Dis . 42 , 360 – 367 . https : / / doi . org / 10 . 1016 / j . nbd . 2011 . 01 . 029 . Arbo , B . D . , Cechinel , L . R . , Palazzo , R . P . , Siqueira , I . R . , 2020 . Endosomal dysfunction impacts extracellular vesicle release : central role in Abeta pathology . Ageing Res . Rev . 58 , 101006 https : / / doi . org / 10 . 1016 / j . arr . 2019 . 101006 . Asai , H . , Ikezu , S . , Tsunoda , S . , Medalla , M . , Luebke , J . , Haydar , T . , Wolozin , B . , Butovsky , O . , Kügler , S . , Ikezu , T . , 2015 . Depletion of microglia and inhibition of exosome synthesis halt tau propagation . Nat . Neurosci . 18 , 1584 – 1593 . https : / / doi . org / 10 . 1038 / nn . 4132 . Aulston , B . , Liu , Q . , Mante , M . , Florio , J . , Rissman , R . A . , Yuan , S . H . , 2019 . Extracellular vesicles isolated from familial Alzheimer ’ s disease neuronal cultures induce aberrant tau phosphorylation in the wild - type mouse brain . J . Alzheimers Dis . 72 , 575 – 585 . https : / / doi . org / 10 . 3233 / JAD - 190656 . Bae , E . J . , Yang , N . Y . , Song , M . , Lee , C . S . , Lee , J . S . , Jung , B . C . , Lee , H . J . , Kim , S . , Masliah , E . , Sardi , S . P . , Lee , S . J . , 2014 . Glucocerebrosidase depletion enhances cell - to - cell transmission of α - synuclein . Nat . Commun . 5 , 4755 . https : / / doi . org / 10 . 1038 / ncomms5755 . Baker , S . , Polanco , J . C . , G ¨ otz , J . , 2016 . Extracellular vesicles containing P301L mutant tau accelerate pathological tau phosphorylation and oligomer formation but do not seed mature neurofibrillary tangles in ALZ17 mice . J . Alzheimers Dis . 54 , 1207 – 1217 . https : / / doi . org / 10 . 3233 / JAD - 160371 . Candelario , K . M . , Balaj , L . , Zheng , T . , Skog , J . , Scheffler , B . , Breakefield , X . , Schüle , B . , Steindler , D . A . , 2020 . Exosome / microvesicle content is altered in leucine - rich repeat kinase 2 mutant induced pluripotent stem cell - derived neural cells . J . Comp . Neurol . 528 , 1203 – 1215 . https : / / doi . org / 10 . 1002 / cne . 24819 . Cataldo , A . M . , Peterhoff , C . M . , Troncoso , J . C . , Gomez - Isla , T . , Hyman , B . T . , Nixon , R . A . , 2000 . Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer ’ s disease and down syndrome : differential effects of APOE genotype and presenilin mutations . Am . J . Pathol . 157 , 277 – 286 . https : / / doi . org / 10 . 1016 / s0002 - 9440 ( 10 ) 64538 - 5 . Cerri , S . , Ghezzi , C . , Ongari , G . , Croce , S . , Avenali , M . , Zangaglia , R . , Di Monte , D . A . , Valente , E . M . , Blandini , F . , 2021 . GBA mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with Parkinson ’ s disease . Int . J . Mol . Sci . 22 , 2215 . https : / / doi . org / 10 . 3390 / ijms22042215 . Chang , D . , Nalls , M . A . , Hallgrímsd ´ ottir , I . B . , Hunkapiller , J . , van der Brug , M . , Cai , F . , International Parkinson ’ s Disease Genomics Consortium ; 23andMe Research Team , Kerchner , G . A . , Ayalon , G . , Bingol , B . , Sheng , M . , Hinds , D . , Behrens , T . W . , Singleton , A . B . , Bhangale , T . R . , Graham , R . R . , 2017 . A meta - analysis of genome - wide association studies identifies 17 new Parkinson ’ s disease risk loci . Nat . Genet . 49 , 1511 – 1516 . https : / / doi . org / 10 . 1038 / ng . 3955 . Chu , Y . , Dodiya , H . , Aebischer , P . , Olanow , C . W . , Kordower , J . H . , 2009 . Alterations in lysosomal and proteasomal markers in Parkinson ’ s disease : relationship to alpha - synuclein inclusions . Neurobiol . Dis . 35 , 385 – 398 . https : / / doi . org / 10 . 1016 / j . nbd . 2009 . 05 . 023 . Clavaguera , F . , Bolmont , T . , Crowther , R . A . , Abramowski , D . , Frank , S . , Probst , A . , Fraser , G . , Stalder , A . K . , Beibel , M . , Staufenbiel , M . , Jucker , M . , Goedert , M . , Tolnay , M . , 2009 . Transmission and spreading of tauopathy in transgenic mouse brain . Nat . Cell Biol . 11 , 909 – 913 . https : / / doi . org / 10 . 1038 / ncb1901 . Crotti , A . , Sait , H . R . , McAvoy , K . M . , Estrada , K . , Ergun , A . , Szak , S . , Marsh , G . , Jandreski , L . , Peterson , M . , Reynolds , T . L . , Dalkilic - Liddle , I . , Cameron , A . , Cahir - McFarland , E . , Ransohoff , R . M . , 2019 . BIN1 favors the spreading of tau via extracellular vesicles . Sci . Rep . 9 , 9477 . https : / / doi . org / 10 . 1038 / s41598 - 019 - 45676 - 0 . David , C . , McPherson , P . S . , Mundigl , O . , de Camilli , P . , 1996 . A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals . Proc . Natl . Acad . Sci . U . S . A . 93 , 331 – 335 . https : / / doi . org / 10 . 1073 / pnas . 93 . 1 . 331 . Dawson , T . M . , Dawson , V . L . , 2010 . The role of parkin in familial and sporadic Parkinson ’ s disease . Mov . Disord . 25 , S32 – S39 . https : / / doi . org / 10 . 1002 / mds . 22798 . DeTure , M . A . , Dickson , D . W . , 2019 . The neuropathological diagnosis of Alzheimer ’ s disease . Mol . Neurodegener . 14 , 32 . https : / / doi . org / 10 . 1186 / s13024 - 019 - 0333 - 5 . Di Fonzo , A . , Chien , H . F . , Socal , M . , Giraudo , S . , Tassorelli , C . , Iliceto , G . , Fabbrini , G . , Marconi , R . , Fincati , E . , Abbruzzese , G . , Marini , P . , Squitieri , F . , Horstink , M . W . , Montagna , P . , Libera , A . D . , Stocchi , F . , Goldwurm , S . , Ferreira , J . J . , Meco , G . , Martignoni , E . , Lopiano , L . , Jardim , L . B . , Oostra , B . A . , Barbosa , E . R . , Italian Parkinson Genetics Network , Bonifati , V . , 2007 . ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease . Neurology 68 , 1557 – 1562 . https : / / doi . org / 10 . 1212 / 01 . wnl . 0000260963 . 08711 . 08 . Dinkins , M . B . , Dasgupta , S . , Wang , G . , Zhu , G . , Bieberich , E . , 2014 . Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer ’ s disease . Neurobiol . Aging 35 , 1792 – 1800 . https : / / doi . org / 10 . 1016 / j . neurobiolaging . 2014 . 02 . 012 . Donaldson , J . G . , 2009 . Phospholipase D in endocytosis and endosomal recycling pathways . Biochim . Biophys . Acta 1791 , 845 – 849 . https : / / doi . org / 10 . 1016 / j . bbalip . 2009 . 05 . 011 . Drouet , V . , Lesage , S . , 2014 . Synaptojanin 1 mutation in Parkinson ’ s disease brings further insight into the neuropathological mechanisms . Biomed . Res . Int . 2014 , 289728 https : / / doi . org / 10 . 1155 / 2014 / 289728 . Eitan , E . , Hutchison , E . R . , Marosi , K . , Comotto , J . , Mustapic , M . , Nigam , S . M . , Suire , C . , Maharana , C . , Jicha , G . A . , Liu , D . , Machairaki , V . , Witwer , K . W . , Kapogiannis , D . , Mattson , M . P . , 2016a . Extracellular vesicle - associated A β mediates trans - neuronal bioenergetic and Ca 2 + - handling deficits in Alzheimer ’ s disease models . NPJ Aging Mech . Dis . 2 , 16019 . https : / / doi . org / 10 . 1038 / npjamd . 2016 . 19 . Eitan , E . , Suire , C . , Zhang , S . , Mattson , M . P . , 2016b . Impact of lysosome status on extracellular vesicle content and release . Ageing Res . Rev . 32 , 65 – 74 . https : / / doi . org / 10 . 1016 / j . arr . 2016 . 05 . 001 . Elkin , S . R . , Lakoduc , A . M . , Schmid , S . L . , 2016 . Endocytic pathways and endosomal trafficking : a primer . Wien . Med . Wochenschr . 166 , 196 – 204 . https : / / doi . org / 10 . 1007 / s10354 - 016 - 0432 - 7 . Elsherbini , A . , Qin , H . , Zhu , Z . , Tripathi , P . , Crivelli , S . M . , Bieberich , E . , 2020 . In vivo evidence of exosome - mediated A β neurotoxicity . Acta Neuropathol . Commun . 8 , 100 . https : / / doi . org / 10 . 1186 / s40478 - 020 - 00981 - y . Emmanouilidou , E . , Melachroinou , K . , Roumeliotis , T . , Garbis , S . D . , Ntzouni , M . , Margaritis , L . H . , Stefanis , L . , Vekrellis , K . , 2010 . Cell - produced alpha - synuclein is secreted in a calcium - dependent manner by exosomes and impacts neuronal survival . J . Neurosci . 30 , 6838 – 6851 . https : / / doi . org / 10 . 1523 / JNEUROSCI . 5699 - 09 . 2010 . Erb , M . L . , Moore , D . J . , 2020 . LRRK2 and the endolysosomal system in Parkinson ’ s disease . J . Parkinsons Dis . 10 , 1271 – 1291 . https : / / doi . org / 10 . 3233 / JPD - 202138 . Fader , C . M . , S ´ anchez , D . , Furl ´ an , M . , Colombo , M . I . , 2008 . Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells . Traffic . 9 , 230 – 250 . https : / / doi . org / 10 . 1111 / j . 1600 - 0854 . 2007 . 00677 . x . Fiandaca , M . S . , Kapogiannis , D . , Mapstone , M . , Boxer , A . , Eitan , E . , Schwartz , J . B . , Abner , E . L . , Petersen , R . C . , Federoff , H . J . , Miller , B . L . , Goetzl , E . J . , 2015 . Identification of preclinical Alzheimer ’ s disease by a profile of pathogenic proteins in neurally derived blood exosomes : a case - control study . Alzheimers Dement . 11 https : / / doi . org / 10 . 1016 / j . jalz . 2014 . 06 . 008 , 600 – 7 . e1 . Fjorback , A . W . , Andersen , O . M . , 2012 . SorLA is a molecular link for retromer - dependent sorting of the amyloid precursor protein . Commun . Integr . Biol . 5 , 616 – 619 . https : / / doi . org / 10 . 4161 / cib . 21433 . Gauthier , N . C . , Monzo , P . , Gonzalez , T . , Doye , A . , Oldani , A . , Gounon , P . , Ricci , V . , Cormont , M . , Boquet , P . , 2007 . Early endosomes associated with dynamic F - actin structures are required for late trafficking of H . pylori VacA toxin . J . Cell Biol . 177 , 343 – 354 . https : / / doi . org / 10 . 1083 / jcb . 200609061 . Gauthier , S . A . , P ´ erez - Gonz ´ alez , R . , Sharma , A . , Huang , F . K . , Alldred , M . J . , Pawlik , M . , Kaur , G . , Ginsberg , S . D . , Neubert , T . A . , Levy , E . , 2017 . Enhanced exosome secretion in down syndrome brain - a protective mechanism to alleviate neuronal endosomal abnormalities . Acta Neuropathol . Commun . 5 , 65 . https : / / doi . org / 10 . 1186 / s40478 - 017 - 0466 - 0 . Gegg , M . E . , Burke , D . , Heales , S . J . , Cooper , J . M . , Hardy , J . , Wood , N . W . , Schapira , A . H . , 2012 . Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains . Ann . Neurol . 72 , 455 – 463 . https : / / doi . org / 10 . 1002 / ana . 23614 . Giovedi , S . , Ravanelli , M . M . , Parisi , B . , Bettegazzi , B . , Guarnieri , F . C . , 2020 . Dysfunctional autophagy and endolysosomal system in neurodegenerative diseases : relevance and therapeutic options . Front . Cell . Neurosci . 14 , 602116 https : / / doi . org / 10 . 3389 / fncel . 2020 . 602116 . M . Izco et al . Neurobiology of Disease 166 ( 2022 ) 105651 8 Goetzl , E . J . , Abner , E . L . , Jicha , G . A . , Kapogiannis , D . , Schwartz , J . B . , 2018 . Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer ’ s disease . FASEB J . 32 , 888 – 893 . https : / / doi . org / 10 . 1096 / fj . 201700731R . Gouwens , L . K . , Ismail , M . S . , Rogers , V . A . , Zeller , N . T . , Garrad , E . C . , Amtashar , F . S . , Makoni , N . J . , Osborn , D . C . , Nichols , M . R . , 2018 . A β 42 protofibrils interact with and are trafficked through microglial - derived microvesicles . ACS Chem . Neurosci . 9 , 1416 – 1425 . https : / / doi . org / 10 . 1021 / acschemneuro . 8b00029 . Guimas Almeida , C . , Sadat Mirfakhar , F . , Perdig ˜ ao , C . , Burrinha , T . , 2018 . Impact of late - onset Alzheimer ’ s genetic risk factors on beta - amyloid endocytic production . Cell . Mol . Life Sci . 75 , 2577 – 2589 . https : / / doi . org / 10 . 1007 / s00018 - 018 - 2825 - 9 . Guo , M . , Wang , J . , Zhao , Y . , Feng , Y . , Han , S . , Dong , Q . , Cui , M . , Tieu , K . , 2020 . Microglial exosomes facilitate α - synuclein transmission in Parkinson ’ s disease . Brain 143 , 1476 – 1497 . https : / / doi . org / 10 . 1093 / brain / awaa090 . Han , C . , Xiong , N . , Guo , X . , Huang , J . , Ma , K . , Liu , L . , Xia , Y . , Shen , Y . , Li , J . , Jiang , H . , Wang , L . , Guo , S . , Xu , X . , Zhang , G . , Liu , J . , Cao , X . , Zhang , Z . , Lin , Z . , Wang , T . , 2019 . Exosomes from patients with Parkinson ’ s disease are pathological in mice . J . Mol . Med . ( Berl ) . 97 , 1329 – 1344 . https : / / doi . org / 10 . 1007 / s00109 - 019 - 01810 - z . Harold , D . , Abraham , R . , Hollingworth , P . , Sims , R . , Gerrish , A . , Hamshere , M . L . , et al . , 2009 . Genome - wide association study identifies variants at CLU and PICALM associated with Alzheimer ’ s disease . Nat . Genet . 41 , 1088 – 1093 . https : / / doi . org / 10 . 1038 / ng . 440 . Hessvik , N . P . , Llorente , A . , 2018 . Current knowledge on exosome biogenesis and release . Cell . Mol . Life Sci . 75 , 193 – 208 . https : / / doi . org / 10 . 1007 / s00018 - 017 - 2595 - 9 . Homma , Y . , Hiragi , S . , Fukuda , M . , 2021 . Rab family of small GTPases : an updated view on their regulation and functions . FEBS J . 288 , 36 – 55 . https : / / doi . org / 10 . 1111 / febs . 15453 . Howitt , J . , Hill , A . F . , 2016 . Exosomes in the pathology of neurodegenerative diseases . J . Biol . Chem . 291 , 26589 – 26597 . https : / / doi . org / 10 . 1074 / jbc . R116 . 757955 . Huotari , J . , Helenius , A . , 2011 . Endosome maturation . EMBO J . 30 , 3481 – 3500 . https : / / doi . org / 10 . 1038 / emboj . 2011 . 286 . Hurwitz , S . N . , Sun , L . , Cole , K . Y . , Ford 3rd , C . R . , Olcese , J . M . , Meckes Jr . , D . G . , 2018 . An optimized method for enrichment of whole brain - derived extracellular vesicles reveals insight into neurodegenerative processes in a mouse model of Alzheimer ’ s disease . J . Neurosci . Methods 307 , 210 – 220 . https : / / doi . org / 10 . 1016 / j . jneumeth . 2018 . 05 . 022 . Izco , M . , Carlos , E . , Alvarez - Erviti , L . , 2021 . The two faces of exosomes in Parkinson ’ s disease : from pathology to therapy . Neuroscientist . 3 https : / / doi . org / 10 . 1177 / 1073858421990001 , 1073858421990001 . Jacquet , A . R . , Tancredi , J . L . , DeSantis , M . C . , Li , W . P . , O ’ Shea , E . K . , 2020 . The LRRK2 G2019S mutation alters astrocyte - to - neuron communication via extracelular vesicles and induces neuron atrophy in a human iPSC - derived model of Parkinson ’ s disease . BioRxiv . Epub Jul 2 . https : / / doi . org / 10 . 1101 / 2020 . 07 . 02 . 178574 . Jellinger , K . A . , 2010 . Basic mechanisms of neurodegeneration : a critical update . J . Cell . Mol . Med . 14 , 457 – 487 . https : / / doi . org / 10 . 1111 / j . 1582 - 4934 . 2010 . 01010 . x . Jewett , K . A . , Thomas , R . E . , Phan , C . Q . , Lin , B . , Milstein , G . , Yu , S . , Bettcher , L . F . , Neto , F . C . , Djukovic , D . , Raftery , D . , Pallanck , L . J . , Davis , M . Y . , 2021 . Glucocerebrosidase reduces the spread of protein aggregation in a Drosophila melanogaster model of neurodegeneration by regulating proteins trafficked by extracellular vesicles . PLoS Genet . 17 , e1008859 https : / / doi . org / 10 . 1371 / journal . pgen . 1008859 . Kalia , L . V . , Lang , A . E . , 2015 . Parkinson ’ s disease . Lancet . 386 , 896 – 912 . https : / / doi . org / 10 . 1016 / S0140 - 6736 ( 14 ) 61393 - 3 . Kanemoto , S . , Nitani , R . , Murakami , T . , Kaneko , M . , Asada , R . , Matsuhisa , K . , Saito , A . , Imaizumi , K . , 2016 . Multivesicular body formation enhancement and exosome release during endoplasmic reticulum stress . Biochem . Biophys . Res . Commun . 480 , 166 – 172 . https : / / doi . org / 10 . 1016 / j . bbrc . 2016 . 10 . 019 . Kett , L . R . , Dauer , W . T . , 2016 . Endolysosomal dysfunction in Parkinson ’ s disease : recent developments and future challenges . Mov . Disord . 31 , 1433 – 1443 . https : / / doi . org / 10 . 1002 / mds . 26797 . King , H . W . , Michael , M . Z . , Gleadle , J . M . , 2012 . Hypoxic enhancement of exosome release by breast cancer cells . BMC Cancer 12 , 421 . https : / / doi . org / 10 . 1186 / 1471 - 2407 - 12 - 421 . Kong , S . M . , Chan , B . K . , Park , J . S . , Hill , K . J . , Aitken , J . B . , Cottle , L . , Farghaian , H . , Cole , A . R . , Lay , P . A . , Sue , C . M . , Cooper , A . A . , 2014 . Parkinson ’ s disease - linked human PARK9 / ATP13A2 maintains zinc homeostasis and promotes α - synuclein externalization via exosomes . Hum . Mol . Genet . 23 , 2816 – 2833 . https : / / doi . org / 10 . 1093 / hmg / ddu099 . Lai , S . S . M . , Ng , K . Y . , Koh , R . Y . , Chok , K . C . , Chye , S . M . , 2021 . Endosomal - lysosomal dysfunctions in Alzheimer ’ s disease : pathogenesis and therapeutic interventions . Metab . Brain Dis . 36 , 1087 – 1100 . https : / / doi . org / 10 . 1007 / s11011 - 021 - 00737 - 0 . Lamb , C . A . , Dooley , H . C . , Tooze , S . A . , 2013 . Endocytosis and autophagy : shared machinery for degradation . Bioessays . 35 , 34 – 45 . https : / / doi . org / 10 . 1002 / bies . 201200130 . Ledreux , A . , Thomas , S . , Hamlett , E . D . , Trautman , C . , Gilmore , A . , Hager , E . R . , Paredes , D . A . , Margittai , M . , Fortea , J . , Granholm , A . C . , 2021 . Small neuron - derived extracellular vesicles from individuals with down syndrome propagate tau pathology in the wildtype mouse brain . J . Clin . Med . 10 , 3931 . https : / / doi . org / 10 . 3390 / jcm10173931 . Lees , A . J . , Hardy , J . , Revesz , T . , 2009 . Parkinson ’ s disease . Lancet 373 , 2055 – 2066 . https : / / doi . org / 10 . 1016 / S0140 - 6736 ( 09 ) 60492 - X . Lehmann , B . D . , Paine , M . S . , Brooks , A . M . , McCubrey , J . A . , Renegar , R . H . , Wang , R . , Terrian , D . M . , 2008 . Senescence - associated exosome release from human prostate cancer cells . Cancer Res . 68 , 7864 – 7871 . https : / / doi . org / 10 . 1158 / 0008 - 5472 . can - 07 - 6538 . Lev , N . , Roncevic , D . , Ickowicz , D . , Melamed , E . , Offen , D . , 2006 . Role of DJ - 1 in Parkinson ’ s disease . J . Mol . Neurosci . 29 , 215 – 225 . https : / / doi . org / 10 . 1385 / jmn : 29 : 3 : 215 . Li , X . , DiFiglia , M . , 2012 . The recycling endosome and its role in neurological disorders . Prog . Neurobiol . 97 , 127 – 141 . https : / / doi . org / 10 . 1016 / j . pneurobio . 2011 . 10 . 002 . Meyerholz , A . , Hinrichsen , L . , Groos , S . , Esk , P . C . , Brandes , G . , Ungewickell , E . J . , 2005 . Effect of clathrin assembly lymphoid myeloid leukemia protein depletion on clathrin coat formation . Traffic . 6 , 1225 – 1234 . https : / / doi . org / 10 . 1111 / j . 1600 - 0854 . 2005 . 00355 . x . Meyer - Luehmann , M . , Coomaraswamy , J . , Bolmont , T . , Kaeser , S . , Schaefer , C . , Kilger , E . , Neuenschwander , A . , Abramowski , D . , Frey , P . , Jaton , A . L . , Vigouret , J . M . , Paganetti , P . , Walsh , D . M . , Mathews , P . M . , Ghiso , J . , Staufenbiel , M . , Walker , L . C . , Jucker , M . , 2006 . Exogenous induction of cerebral beta - amyloidogenesis is governed by agent and host . Science 313 , 1781 – 1784 . https : / / doi . org / 10 . 1126 / science . 1131864 . Miranda , A . M . , Lasiecka , Z . M . , Xu , Y . , Neufeld , J . , Shahriar , S . , Simoes , S . , Chan , R . B . , Oliveira , T . G . , Small , S . A . , Di Paolo , G . , 2018 . Neuronal lysosomal dysfunction releases exosomes harboring APP C - terminal fragments and unique lipid signatures . Nat . Commun . 9 , 291 . https : / / doi . org / 10 . 1038 / s41467 - 017 - 02533 - w . Murphy , K . E . , Gysbers , A . M . , Abbott , S . K . , Tayebi , N . , Kim , W . S . , Sidransky , E . , Cooper , A . , Garner , B . , Halliday , G . M . , 2014 . Reduced glucocerebrosidase is associated with increased α - synuclein in sporadic Parkinson ’ s disease . Brain 137 , 834 – 848 . https : / / doi . org / 10 . 1093 / brain / awt367 . Ngolab , J . , Trinh , I . , Rockenstein , E . , Mante , M . , Florio , J . , Trejo , M . , Masliah , D . , Adame , A . , Masliah , E . , Rissman , R . A . , 2017 . Brain - derived exosomes from dementia with Lewy bodies propagate α - synuclein pathology . Acta Neuropathol . Commun . 5 , 46 . https : / / doi . org / 10 . 1186 / s40478 - 017 - 0445 - 5 . Nikitidou , E . , Khoonsari , P . E . , Shevchenko , G . , Ingelsson , M . , Kultima , K . , Erlandsson , A . , 2017 . Increased release of Apolipoprotein E in extracellular vesicles following amyloid - β protofibril exposure of neuroglial co - cultures . J . Alzheimers Dis . 60 , 305 – 321 . https : / / doi . org / 10 . 3233 / JAD - 170278 . Nuriel , T . , Peng , K . Y . , Ashok , A . , Dillman , A . A . , Figueroa , H . Y . , Apuzzo , J . , Ambat , J . , Levy , E . , Cookson , M . R . , Mathews , P . M . , Duff , K . E . , 2017 . The endosomal - lysosomal pathway is dysregulated by APOE4 expression in vivo . Front . Neurosci . 11 , 702 . https : / / doi . org / 10 . 3389 / fnins . 2017 . 00702 . Olgiati , S . , Quadri , M . , Fang , M . , Rood , J . P . , Saute , J . A . , Chien , H . F . , Bouwkamp , C . G . , Graafland , J . , Minneboo , M . , Breedveld , G . J . , Zhang , J . , International Parkinsonism Genetics Network , Verheijen , F . W . , Boon , A . J . , Kievit , A . J . , Jardim , L . B . , Mandemakers , W . , Barbosa , E . R . , Rieder , C . R . , Leenders , K . L . , Wang , J . , Bonifati , V . , 2016 . DNAJC6 mutations associated with early - onset Parkinson ’ s disease . Ann . Neurol . 79 , 244 – 256 . https : / / doi . org / 10 . 1002 / ana . 24553 . Ortega , F . G . , Roefs , M . T . , de Miguel Perez , D . , Kooijmans , S . A . , de Jong , O . G . , Sluijter , J . P . , Schiffelers , R . M . , Vader , P . , 2019 . Interfering with endolysosomal trafficking enhances release of bioactive exosomes . Nanomedicine . 20 , 102014 https : / / doi . org / 10 . 1016 / j . nano . 2019 . 102014 . Papadopoulos , V . E . , Nikolopoulou , G . , Antoniadou , I . , Karachaliou , A . , Arianoglou , G . , Emmanouilidou , E . , Sardi , S . P . , Stefanis , L . , Vekrellis , K . , 2018 . Modulation of β - glucocerebrosidase increases α - synuclein secretion and exosome release in mouse models of Parkinson ’ s disease . Hum . Mol . Genet . 27 , 1696 – 1710 . https : / / doi . org / 10 . 1093 / hmg / ddy075 . Peng , K . Y . , P ´ erez - Gonz ´ alez , R . , Alldred , M . J . , Goulbourne , C . N . , Morales - Corraliza , J . , Saito , M . , Saito , M . , Ginsberg , S . D . , Mathews , P . M . , Levy , E . , 2019 . Apolipoprotein E4 genotype compromises brain exosome production . Brain 142 , 163 – 175 . https : / / doi . org / 10 . 1093 / brain / awy289 . Perez - Gonzalez , R . , Gauthier , S . A . , Kumar , A . , Levy , E . , 2012 . The exosome secretory pathway transports amyloid precursor protein carboxyl - terminal fragments from the cell into the brain extracellular space . J . Biol . Chem . 287 , 43108 – 43115 . https : / / doi . org / 10 . 1074 / jbc . M112 . 404467 . P ´ erez - Gonz ´ alez , R . , Kim , Y . , Miller , C . , Pacheco - Quinto , J . , Eckman , E . A . , Levy , E . , 2020 . Extracellular vesicles : where the amyloid precursor protein carboxyl - terminal fragments accumulate and amyloid - β oligomerizes . FASEB J . 34 , 12922 – 12931 . https : / / doi . org / 10 . 1096 / fj . 202000823R . Piper , R . C . , Katzmann , D . J . , 2007 . Biogenesis and function of multivesicular bodies . Annu . Rev . Cell Dev . Biol . 23 , 519 – 547 . https : / / doi . org / 10 . 1146 / annurev . cellbio . 23 . 090506 . 123319 . Polanco , J . C . , Scicluna , B . J . , Hill , A . F . , G ¨ otz , J . , 2016 . Extracellular vesicles isolated from the brains of rTg4510 mice seed tau protein aggregation in a threshold - dependent manner . J . Biol . Chem . 291 , 12445 – 12466 . https : / / doi . org / 10 . 1074 / jbc . M115 . 709485 . Polymeropoulos , M . H . , Lavedan , C . , Leroy , E . , Ide , S . E . , Dehejia , A . , Dutra , A . , Pike , B . , Root , H . , Rubenstein , J . , Boyer , R . , Stenroos , E . S . , Chandrasekharappa , S . , Athanassiadou , A . , Papapetropoulos , T . , Johnson , W . G . , Lazzarini , A . M . , Duvoisin , R . C . , Di Iorio , G . , Golbe , L . I . , Nussbaum , R . L . , 1997 . Mutation in the alpha - synuclein gene identified in families with Parkinson ’ s disease . Science 276 , 2045 – 2047 . https : / / doi . org / 10 . 1126 / science . 276 . 5321 . 2045 . Rajendran , L . , Honsho , M . , Zahn , T . R . , Keller , P . , Geiger , K . D . , Verkade , P . , Simons , K . , 2006 . Alzheimer ’ s disease beta - amyloid peptides are released in association with exosomes . Proc . Natl . Acad . Sci . U . S . A . 103 , 11172 – 11177 . https : / / doi . org / 10 . 1073 / pnas . 0603838103 . Ramirez , A . , Heimbach , A . , Gründemann , J . , Stiller , B . , Hampshire , D . , Cid , L . P . , Goebel , I . , Mubaidin , A . F . , Wriekat , A . L . , Roeper , J . , Al - Din , A . , Hillmer , A . M . , Karsak , M . , Liss , B . , Woods , C . G . , Behrens , M . I . , Kubisch , C . , 2006 . Hereditary parkinsonism with dementia is caused by mutations in ATP13A2 , encoding a lysosomal type 5 P - type ATPase . Nat . Genet . 38 , 1184 – 1191 . https : / / doi . org / 10 . 1038 / ng1884 . M . Izco et al . Neurobiology of Disease 166 ( 2022 ) 105651 9 Raposo , G . , Stoorvogel , W . , 2013 . Extracellular vesicles : exosomes , microvesicles , and friends . J . Cell Biol . 200 , 373 – 383 . https : / / doi . org / 10 . 1083 / jcb . 201211138 . Reilly , P . , Winston , C . N . , Baron , K . R . , Trejo , M . , Rockenstein , E . M . , Akers , J . C . , Kfoury , N . , Diamond , M . , Masliah , E . , Rissman , R . A . , Yuan , S . H . , 2017 . Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation . Neurobiol . Dis . 106 , 222 – 234 . https : / / doi . org / 10 . 1016 / j . nbd . 2017 . 06 . 005 . Rocha , E . M . , Smith , G . A . , Park , E . , Cao , H . , Brown , E . , Hallett , P . , Isacson , O . , 2015 . Progressive decline of glucocerebrosidase in aging and Parkinson ’ s disease . Ann . Clin . Transl . Neurol . 2 , 433 – 438 . https : / / doi . org / 10 . 1002 / acn3 . 177 . Rocha , E . M . , De Miranda , B . R . , Castro , S . , Drolet , R . , Hatcher , N . G . , Yao , L . , Smith , S . M . , Keeney , M . T . , Di Maio , R . , Kofler , J . , Hastings , T . G . , Greenamyre , J . T . , 2020 . LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson ’ s disease . Neurobiol . Dis . 134 , 104626 https : / / doi . org / 10 . 1016 / j . nbd . 2019 . 104626 . Rui , Q . , Ni , H . , Li , D . , Gao , R . , Chen , G . , 2018 . The role of LRRK2 in neurodegeneration of Parkinson disease . Curr . Neuropharmacol . 16 , 1348 – 1357 . https : / / doi . org / 10 . 2174 / 1570159X16666180222165418 . Saman , S . , Kim , W . , Raya , M . , Visnick , Y . , Miro , S . , Saman , S . , Jackson , B . , McKee , A . C . , Alvarez , V . E . , Lee , N . C . , Hall , G . F . , 2012 . Exosome - associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease . J . Biol . Chem . 287 , 3842 – 3849 . https : / / doi . org / 10 . 1074 / jbc . M111 . 277061 . Sardar Sinha , M . , Ansell - Schultz , A . , Civitelli , L . , Hildesj ¨ o , C . , Larsson , M . , Lannfelt , L . , Ingelsson , M . , Hallbeck , M . , 2018 . Alzheimer ’ s disease pathology propagation by exosomes containing toxic amyloid - beta oligomers . Acta Neuropathol . 136 , 41 – 56 . https : / / doi . org / 10 . 1007 / s00401 - 018 - 1868 - 1 . Satake , W . , Nakabayashi , Y . , Mizuta , I . , Hirota , Y . , Ito , C . , Kubo , M . , Kawaguchi , T . , Tsunoda , T . , Watanabe , M . , Takeda , A . , Tomiyama , H . , Nakashima , K . , Hasegawa , K . , Obata , F . , Yoshikawa , T . , Kawakami , H . , Sakoda , S . , Yamamoto , M . , Hattori , N . , Murata , M . , Nakamura , Y . , Toda , T . , 2009 . Genome - wide association study identifies common variants at four loci as genetic risk factors for Parkinson ’ s disease . Nat . Genet . 41 , 1303 – 1307 . https : / / doi . org / 10 . 1038 / ng . 485 . Schapira , A . H . V . , Chaudhuri , K . R . , Jenner , P . , 2017 . Non - motor features of Parkinson disease . Nat . Rev . Neurosci . 18 , 435 – 450 . https : / / doi . org / 10 . 1038 / nrn . 2017 . 62 . Schormair , B . , Kemlink , D . , Mollenhauer , B . , Fiala , O . , Machetanz , G . , Roth , J . , Berutti , R . , Strom , T . M . , Haslinger , B . , Trenkwalder , C . , Zahorakova , D . , Martasek , P . , Ruzicka , E . , Winkelmann , J . , 2018 . Diagnostic exome sequencing in early - onset Parkinson ’ s disease confirms VPS13C as a rare cause of autosomal - recessive Parkinson ’ s disease . Clin . Genet . 93 , 603 – 612 . https : / / doi . org / 10 . 1111 / cge . 13124 . Scott , C . C . , Vacca , F . , Gruenberg , J . , 2014 . Endosome maturation , transport and functions . Semin . Cell Dev . Biol . 31 , 2 – 10 . https : / / doi . org / 10 . 1016 / j . semcdb . 2014 . 03 . 034 . Seaman , M . N . J . , 2012 . The retromer complex – endosomal protein recycling and beyond . J . Cell Sci . 125 , 4693 – 4702 . https : / / doi . org / 10 . 1242 / jcs . 103440 . Serrano - Pozo , A . , Frosch , M . P . , Masliah , E . , Hyman , B . T . , 2011 . Neuropathological alterations in Alzheimer disease . Cold Spring Harb . Perspect . Med . 1 , a006189 https : / / doi . org / 10 . 1101 / cshperspect . a006189 . Shen , R . , Zhao , X . , He , L . , Ding , Y . , Xu , W . , Lin , S . , Fang , S . , Yang , W . , Sung , K . , Spencer , B . , Rissman , R . A . , Lei , M . , Ding , J . , Wu , C . , 2020 . Upregulation of RIN3 induces endosomal dysfunction in Alzheimer ’ s disease . Transl . Neurodegener . 9 , 26 . https : / / doi . org / 10 . 1186 / s40035 - 020 - 00206 - 1 . Sidransky , E . , Lopez , G . , 2012 . The link between the GBA gene and parkinsonism . Lancet Neurol . 11 , 986 – 998 . https : / / doi . org / 10 . 1016 / S1474 - 4422 ( 12 ) 70190 - 4 . Singleton , A . B . , Farrer , M . , Johnson , J . , Singleton , A . , Hague , S . , Kachergus , J . , Hulihan , M . , Peuralinna , T . , Dutra , A . , Nussbaum , R . , Lincoln , S . , Crawley , A . , Hanson , M . , Maraganore , D . , Adler , C . , Cookson , M . R . , Muenter , M . , Baptista , M . , Miller , D . , Blancato , J . , Hardy , J . , Gwinn - Hardy , K . , 2003 . Alpha - Synuclein locus triplication causes Parkinson ’ s disease . Science 302 , 841 . https : / / doi . org / 10 . 1126 / science . 1090278 . Sinha , S . , Hoshino , D . , Hong , N . H . , Kirkbride , K . C . , Grega - Larson , N . E . , Seiki , M . , Tyska , M . J . , Weaver , A . M . , 2016 . Cortactin promotes exosome secretion by controlling branched actin dynamics . J . Cell Biol . 214 , 197 – 213 . https : / / doi . org / 10 . 1083 / jcb . 201601025 . Song , P . , Trajkovic , K . , Tsunemi , T . , Krainc , D . , 2016 . Parkin modulates endosomal organization and function of the endo - lysosomal pathway . J . Neurosci . 36 , 2425 – 2437 . https : / / doi . org / 10 . 1523 / JNEUROSCI . 2569 - 15 . 2016 . Song , Z . , Xu , Y . , Deng , W . , Zhang , L . , Zhu , H . , Yu , P . , Qu , Y . , Zhao , W . , Han , Y . , Qin , C . , 2020 . Brain derived exosomes are a double - edged sword in Alzheimer ’ s disease . Front . Mol . Neurosci . 13 , 79 . https : / / doi . org / 10 . 3389 / fnmol . 2020 . 00079 . Stuendl , A . , Kunadt , M . , Kruse , N . , Bartels , C . , Moebius , W . , Danzer , K . M . , Mollenhauer , B . , Schneider , A . , 2016 . Induction of α - synuclein aggregate formation by CSF exosomes from patients with Parkinson ’ s disease and dementia with Lewy bodies . Brain 139 , 481 – 494 . https : / / doi . org / 10 . 1093 / brain / awv346 . Stykel , M . G . , Humphries , K . M . , Kamski - Hennekam , E . , Buchner - Duby , B . , Porte - Trachsel , N . , Ryan , T . , Coackley , C . L . , Bamm , V . V . , Harauz , G . , Ryan , S . D . , 2021 . α - Synuclein mutation impairs processing of endomembrane compartments and promotes exocytosis and seeding of α - synuclein pathology . Cell Rep . 35 , 109099 https : / / doi . org / 10 . 1016 / j . celrep . 2021 . 109099 . Sullivan , C . P . , Jay , A . G . , Stack , E . C . , Pakaluk , M . , Wadlinger , E . , Fine , R . E . , Wells , J . M . , Morin , P . J . , 2011 . Retromer disruption promotes amyloidogenic APP processing . Neurobiol . Dis . 43 , 338 – 345 . https : / / doi . org / 10 . 1016 / j . nbd . 2011 . 04 . 002 . Thomas , R . E . , Vincow , E . S . , Merrihew , G . E . , MacCoss , M . J . , Davis , M . Y . , Pallanck , L . J . , 2018 . Glucocerebrosidase deficiency promotes protein aggregation through dysregulation of extracellular vesicles . PLoS Genet . 14 , e1007694 https : / / doi . org / 10 . 1371 / journal . pgen . 1007694 . Trajkovic , K . , Hsu , C . , Chiantia , S . , Rajendran , L . , Wenzel , D . , Wieland , F . , Schwille , P . , Brügger , B . , Simons , M . , 2008 . Ceramide triggers budding of exosome vesicles into multivesicular endosomes . Science 319 , 1244 – 1247 . https : / / doi . org / 10 . 1126 / science . 1153124 . Tsunemi , T . , Hamada , K . , Krainc , D . , 2014 . ATP13A2 / PARK9 regulates secretion of exosomes and α - synuclein . J . Neurosci . 34 , 15281 – 15287 . https : / / doi . org / 10 . 1523 / JNEUROSCI . 1629 - 14 . 2014 . Tsunemi , T . , Ishiguro , Y . , Yoroisaka , A . , Valdez , C . , Miyamoto , K . , Ishikawa , K . , Saiki , S . , Akamatsu , W . , Hattori , N . , Krainc , D . , 2020 . Astrocytes protect human dopaminergic neurons from α - synuclein accumulation and propagation . J . Neurosci . 40 , 8618 – 8628 . https : / / doi . org / 10 . 1523 / JNEUROSCI . 0954 - 20 . 2020 . Valente , E . M . , Abou - Sleiman , P . M . , Caputo , V . , Muqit , M . M . , Harvey , K . , Gispert , S . , Ali , Z . , Del Turco , D . , Bentivoglio , A . R . , Healy , D . G . , Albanese , A . , Nussbaum , R . , Gonz ´ alez - Maldonado , R . , Deller , T . , Salvi , S . , Cortelli , P . , Gilks , W . P . , Latchman , D . S . , Harvey , R . J . , Dallapiccola , B . , Auburger , G . , Wood , N . W . , 2004 . Hereditary early - onset Parkinson ’ s disease caused by mutations in PINK1 . Science 304 , 1158 – 1160 . https : / / doi . org / 10 . 1126 / science . 1096284 . Van Acker , Z . P . , Bretou , M . , Annaert , W . , 2019 . Endo - lysosomal dysregulations and late - onset Alzheimer ’ s disease : impact of genetic risk factors . Mol . Neurodegener . 14 , 20 . https : / / doi . org / 10 . 1186 / s13024 - 019 - 0323 - 7 . Vidyadhara , D . J . , Lee , J . E . , Chandra , S . S . , 2019 . Role of the endolysosomal system in Parkinson ’ s disease . J . Neurochem . 150 , 487 – 506 doi : 10 . 1111 / jnc . 14820 . Vilari ˜ no - Güell , C . , Rajput , A . , Milnerwood , A . J . , Shah , B . , Szu - Tu , C . , Trinh , J . , Yu , I . , Encarnacion , M . , Munsie , L . N . , Tapia , L . , Gustavsson , E . K . , Chou , P . , Tatarnikov , I . , Evans , D . M . , Pishotta , F . T . , Volta , M . , Beccano - Kelly , D . , Thompson , C . , Lin , M . K . , Sherman , H . E . , Han , H . J . , Guenther , B . L . , Wasserman , W . W . , Bernard , V . , Ross , C . J . , Appel - Cresswell , S . , Stoessl , A . J . , Robinson , C . A . , Dickson , D . W . , Ross , O . A . , Wszolek , Z . K . , Aasly , J . O . , Wu , R . M . , Hentati , F . , Gibson , R . A . , McPherson , P . S . , Girard , M . , Rajput , M . , Rajput , A . H . , Farrer , M . J . , 2014 . DNAJC13 mutations in Parkinson disease . Hum . Mol . Genet . 23 , 1794 – 1801 . https : / / doi . org / 10 . 1093 / hmg / ddt570 . Villarroya - Beltri , C . , Baixauli , F . , Mittelbrunn , M . , Fern ´ andez - Delgado , I . , Torralba , D . , Moreno - Gonzalo , O . , Baldanta , S . , Enrich , C . , Guerra , S . , S ´ anchez - Madrid , F . , 2016 . ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins . Nat . Commun . 7 , 13588 . https : / / doi . org / 10 . 1038 / ncomms13588 . Walsh , R . B . , Dresselhaus , E . C . , Becalska , A . N . , Zunitch , M . J . , Blanchette , C . R . , Scalera , A . L . , Lemos , T . , Lee , S . M . , Apiki , J . , Wang , S . , Isaac , B . , Yeh , A . , Koles , K . , Rodal , A . A . , 2021 . Opposing functions for retromer and Rab11 in extracellular vesicle traffic at presynaptic terminals . J . Cell Biol . 220 , e202012034 https : / / doi . org / 10 . 1083 / jcb . 202012034 . Wang , C . , Telpoukhovskaia , M . A . , Bahr , B . A . , Chen , X . , Gan , L . , 2017 . Endo - lysosomal dysfunction : a converging mechanism in neurodegenerative diseases . Curr . Opin . Neurobiol . 48 , 52 – 58 . https : / / doi . org / 10 . 1016 / j . conb . 2017 . 09 . 005 . Wang , Y . , Balaji , V . , Kaniyappan , S . , Krüger , L . , Irsen , S . , Tepper , K . , Chandupatla , R . , Maetzler , W . , Schneider , A . , Mandelkow , E . , Mandelkow , E . M . , 2017b . The release and trans - synaptic transmission of Tau via exosomes . Mol . Neurodegener . 12 , 5 . https : / / doi . org / 10 . 1186 / s13024 - 016 - 0143 - y . Wang , X . L . , Feng , S . T . , Wang , Z . Z . , Yuan , Y . H . , Chen , N . H . , Zhang , Y . , 2020 . Parkin , an E3 ubiquitin ligase , plays an essential role in mitochondrial quality control in Parkinson ’ s disease . Cell . Mol . Neurobiol . https : / / doi . org / 10 . 1007 / s10571 - 020 - 00914 - 2 . Williams , E . T . , Chen , X . , Moore , D . J . , 2017 . VPS35 , the retromer complex and Parkinson ’ s disease . J . Parkinsons Dis . 7 , 219 – 233 . https : / / doi . org / 10 . 3233 / JPD - 161020 . Winston , C . N . , Goetzl , E . J . , Akers , J . C . , Carter , B . S . , Rockenstein , E . M . , Galasko , D . , Masliah , E . , Rissman , R . A . , 2016 . Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile . Alzheimers Dement . ( Amst ) . 3 , 63 – 72 . https : / / doi . org / 10 . 1016 / j . dadm . 2016 . 04 . 001 . Winston , C . N . , Aulston , B . , Rockenstein , E . M . , Adame , A . , Prikhodko , O . , Dave , K . N . , Mishra , P . , Rissman , R . A . , Yuan , S . H . , 2019 . Neuronal exosome - derived human tau is toxic to recipient mouse neurons in vivo . J . Alzheimers Dis . 67 , 541 – 553 . https : / / doi . org / 10 . 3233 / JAD - 180776 . Xia , Y . , Zhang , G . , Han , C . , Ma , K . , Guo , X . , Wan , F . , Kou , L . , Yin , S . , Liu , L . , Huang , J . , Xiong , N . , Wang , T . , 2019 . Microglia as modulators of exosomal alpha - synuclein transmission . Cell Death Dis . 10 , 174 . https : / / doi . org / 10 . 1038 / s41419 - 019 - 1404 - 9 . Xiao , T . , Zhang , W . , Jiao , B . , Pan , C . Z . , Liu , X . , Shen , L . , 2017 . The role of exosomes in the pathogenesis of Alzheimer ’ disease . Transl Neurodegener . 6 , 3 . https : / / doi . org / 10 . 1186 / s40035 - 017 - 0072 - x . Xu , J . , Camfield , R . , Gorski , S . M . , 2018 . The interplay between exosomes and autophagy - partners in crime . J . Cell Sci . 131 , jcs215210 . https : / / doi . org / 10 . 1242 / jcs . 215210 . Yin , R . H . , Tan , L . , Jiang , T . , Yu , J . T . , 2014 . Prion - like mechanisms in Alzheimer ’ s disease . Curr . Alzheimer Res . 11 , 755 – 764 . https : / / doi . org / 10 . 2174 / 156720501108140910121425 . Yuan , Q . , Li , X . , Zhang , S . , Wang , H . , Wang , Y . , 2021 . Extracellular vesicles in neurodegenerative diseases : insights and new perspectives . Genes Dis . 8 , 124 – 132 . https : / / doi . org / 10 . 1016 / j . gendis . 2019 . 12 . 001 . Yuyama , K . , Yamamoto , N . , Yanagisawa , K . , 2008 . Accelerated release of exosome - associated GM1 ganglioside ( GM1 ) by endocytic pathway abnormality : another putative pathway for GM1 - induced amyloid fibril formation . J . Neurochem . 105 , 217 – 224 . https : / / doi . org / 10 . 1111 / j . 1471 - 4159 . 2007 . M . Izco et al .